These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

266 related articles for article (PubMed ID: 38198120)

  • 1. Management of Paraneoplastic Syndromes in the Era of Immune Checkpoint Inhibitors.
    Jean MJ; Samkoff L; Mohile N
    Curr Treat Options Oncol; 2024 Jan; 25(1):42-65. PubMed ID: 38198120
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Updates in the Management of Paraneoplastic Syndrome.
    Verma N; Jaffer MH; Kolli AS; Mokhtari S
    Semin Neurol; 2024 Feb; 44(1):36-46. PubMed ID: 38183975
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Paraneoplastic Neurologic Disorders.
    Zekeridou A
    Continuum (Minneap Minn); 2024 Aug; 30(4):1021-1051. PubMed ID: 39088287
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pathogenesis, diagnosis and treatment of paraneoplastic neurologic syndromes.
    Blaes F
    Expert Rev Neurother; 2021 Jun; 21(6):675-686. PubMed ID: 33960258
    [No Abstract]   [Full Text] [Related]  

  • 5. Paraneoplastic Neurological Syndromes: Transitioning Between the Old and the New.
    Gastaldi M; Scaranzin S; Pietro B; Lechiara A; Pesce G; Franciotta D; Lorusso L
    Curr Oncol Rep; 2022 Oct; 24(10):1237-1249. PubMed ID: 35476177
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Paraneoplastic syndromes: a review].
    Berardi R; Grilli G; Romagnoli E; Saladino T; Freddari F; Tamburrano T; Galizia E; Carbonari G; Mariani C; Braconi C; Pierantoni C; Battelli N; Scartozzi M; Cascinu S
    Clin Ter; 2005; 156(6):281-8. PubMed ID: 16463565
    [TBL] [Abstract][Full Text] [Related]  

  • 7. New concepts in paraneoplastic neurological syndromes.
    Honnorat J; Viaccoz A
    Rev Neurol (Paris); 2011 Oct; 167(10):729-36. PubMed ID: 21890156
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Paraneoplastic neurological syndromes--diagnosis and management.
    Blaes F
    Curr Pharm Des; 2012; 18(29):4518-25. PubMed ID: 22612756
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Management of paraneoplastic neurological syndromes: report of an EFNS Task Force.
    Vedeler CA; Antoine JC; Giometto B; Graus F; Grisold W; Hart IK; Honnorat J; Sillevis Smitt PA; Verschuuren JJ; Voltz R;
    Eur J Neurol; 2006 Jul; 13(7):682-90. PubMed ID: 16834698
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Paraneoplastic syndromes].
    Krome S
    Dtsch Med Wochenschr; 2012 Mar; 137 Suppl 1():S20-2. PubMed ID: 22438119
    [No Abstract]   [Full Text] [Related]  

  • 11. Paraneoplastic neurological syndromes: a single institution 10-year case series.
    Chan AM; Baehring JM
    J Neurooncol; 2019 Jan; 141(2):431-439. PubMed ID: 30607708
    [TBL] [Abstract][Full Text] [Related]  

  • 12. S2k guidelines on the management of paraneoplastic pemphigus/paraneoplastic autoimmune multiorgan syndrome initiated by the European Academy of Dermatology and Venereology (EADV).
    Antiga E; Bech R; Maglie R; Genovese G; Borradori L; Bockle B; Caproni M; Caux F; Chandran NS; Corrà A; D'Amore F; Daneshpazhooh M; De D; Didona D; Dmochowski M; Drenovska K; Ehrchen J; Feliciani C; Goebeler M; Groves R; Günther C; Handa S; Hofmann SC; Horvath B; Ioannidis D; Jedlickova H; Kowalewski C; Kridin K; Joly P; Lim YL; Marinovic B; Maverakis E; Meijer J; Patsatsi A; Pincelli C; Prost C; Setterfield J; Sprecher E; Skiljevic D; Tasanen K; Uzun S; Van Beek N; Vassileva S; Vorobyev A; Vujic I; Wang G; Wang M; Wozniak K; Yayli S; Zambruno G; Hashimoto T; Schmidt E; Mascarò JM; Marzano AV
    J Eur Acad Dermatol Venereol; 2023 Jun; 37(6):1118-1134. PubMed ID: 36965110
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Neurological adverse events of immune checkpoint inhibitors and the development of paraneoplastic neurological syndromes.
    Farina A; Villagrán-García M; Vogrig A; Zekeridou A; Muñiz-Castrillo S; Velasco R; Guidon AC; Joubert B; Honnorat J
    Lancet Neurol; 2024 Jan; 23(1):81-94. PubMed ID: 38101905
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CV2/CRMP5-antibody-related Paraneoplastic Neurologic Syndrome Associated with Gastrointestinal Stromal Tumor.
    Fukushima H; Shibuya T; Awatsu T; Kurosawa T; Haga K; Murakami T; Serizawa N; Mori A; Hojo M; Yao T; Hattori N; Nagahara A
    Intern Med; 2022 May; 61(10):1497-1501. PubMed ID: 34670904
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Paraneoplastic Neurologic Disorders.
    Gilligan M; McGuigan C; McKeon A
    Curr Neurol Neurosci Rep; 2023 Mar; 23(3):67-82. PubMed ID: 36781586
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Diagnosis and management of paraneoplastic neurological syndromes].
    Saji E; Kawachi I; Nishizawa M
    Brain Nerve; 2010 Apr; 62(4):319-30. PubMed ID: 20420171
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Paraneoplastic neurological syndromes: unusual presentations of cancer. A practical review.
    Braik T; Evans AT; Telfer M; McDunn S
    Am J Med Sci; 2010 Oct; 340(4):301-8. PubMed ID: 20460982
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Paraneoplastic neurologic syndromes: approaches to diagnosis and treatment.
    Bataller L; Dalmau J
    Semin Neurol; 2003 Jun; 23(2):215-24. PubMed ID: 12894387
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Paraneoplastic neurological syndromes with onconeural antibodies: A single center retrospective study.
    Oliveira V; Videira G; Samões R; Carneiro P; Neves E; Santos E
    J Neurol Sci; 2020 Nov; 418():117103. PubMed ID: 32877801
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Paraneoplastic neurological syndromes.
    Leypoldt F; Wandinger KP
    Clin Exp Immunol; 2014 Mar; 175(3):336-48. PubMed ID: 23937626
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.